Intensity Therapeutics Inc
(INTS)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 3,241 | 7,458 | 8,556 | 6,694 | 136 |
| Marketable Securities | 3,083 | 3,039 | 6,220 | 8,955 | N/A |
| Receivables | N/A | N/A | N/A | N/A | 17,765 |
| Other current assets | 0 | 0 | 0 | 15 | 159 |
| TOTAL | $7,440 | $11,169 | $15,464 | $16,635 | $18,060 |
| Non-Current Assets | |||||
| Other Non-Current Assets | 1,233 | 1,239 | 1,831 | 181 | 168 |
| TOTAL | $1,233 | $1,239 | $1,831 | $181 | $168 |
| Total Assets | $8,673 | $12,408 | $17,295 | $16,816 | $18,228 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,919 | 1,219 | 3,048 | 358 | 1,582 |
| Accrued Expenses | 1,258 | 1,274 | 891 | 355 | 1,477 |
| TOTAL | $3,204 | $2,519 | $3,959 | $724 | $3,058 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 0 | 36 | 36 | 36 | 36 |
| TOTAL | $124 | $167 | $174 | $181 | $36 |
| Total Liabilities | $3,328 | $2,686 | $4,133 | $905 | $3,094 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 13,772 | 13,712 | 13,709 | 13,709 | 13,684 |
| Common Shares | 1 | 1 | 1 | 1 | 1 |
| Retained earnings | -60,089 | -55,118 | -50,515 | -47,343 | -43,690 |
| TOTAL | $5,345 | $9,722 | $13,162 | $15,911 | $15,134 |
| Total Liabilities And Equity | $8,673 | $12,408 | $17,295 | $16,816 | $18,228 |